Cargando…

Rethinking diabetes in the United States

Despite the availability of effective medical treatments, the diabetes epidemic has accelerated in the United States, efforts to translate treatments into routine clinical practice have stalled, and health inequities have persisted. The National Clinical Care Commission (NCCC) was established by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, William H., Schillinger, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310945/
https://www.ncbi.nlm.nih.gov/pubmed/37396183
http://dx.doi.org/10.3389/fendo.2023.1185719
_version_ 1785066641120296960
author Herman, William H.
Schillinger, Dean
author_facet Herman, William H.
Schillinger, Dean
author_sort Herman, William H.
collection PubMed
description Despite the availability of effective medical treatments, the diabetes epidemic has accelerated in the United States, efforts to translate treatments into routine clinical practice have stalled, and health inequities have persisted. The National Clinical Care Commission (NCCC) was established by the Congress to make recommendations to better leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC developed a guiding framework that incorporated elements of the Socioecological and Chronic Care Models. It gathered information from both health-related and non-health-related federal agencies, held 12 public meetings, solicited public comments, met with interested parties and key informants, and performed comprehensive literature reviews. The final report of the NCCC was transmitted to the Congress in January 2022. It called for a rethinking of the problem of diabetes in the United States, including the recognition that the lack of progress is due to a failure to confront diabetes as both a complex societal problem as well as a biomedical problem. To prevent and control diabetes, public policies and programs must be aligned to address both social and environmental determinants of health and health care delivery as they impact diabetes. In this article, we discuss the findings and recommendations of the NCCC as they relate to the social and environmental factors that influence the risk of type 2 diabetes and argue that the prevention and control of type 2 diabetes in the U.S. must begin with concrete population-level interventions to address social and environmental determinants of health.
format Online
Article
Text
id pubmed-10310945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103109452023-07-01 Rethinking diabetes in the United States Herman, William H. Schillinger, Dean Front Endocrinol (Lausanne) Endocrinology Despite the availability of effective medical treatments, the diabetes epidemic has accelerated in the United States, efforts to translate treatments into routine clinical practice have stalled, and health inequities have persisted. The National Clinical Care Commission (NCCC) was established by the Congress to make recommendations to better leverage federal policies and programs to more effectively prevent and control diabetes and its complications. The NCCC developed a guiding framework that incorporated elements of the Socioecological and Chronic Care Models. It gathered information from both health-related and non-health-related federal agencies, held 12 public meetings, solicited public comments, met with interested parties and key informants, and performed comprehensive literature reviews. The final report of the NCCC was transmitted to the Congress in January 2022. It called for a rethinking of the problem of diabetes in the United States, including the recognition that the lack of progress is due to a failure to confront diabetes as both a complex societal problem as well as a biomedical problem. To prevent and control diabetes, public policies and programs must be aligned to address both social and environmental determinants of health and health care delivery as they impact diabetes. In this article, we discuss the findings and recommendations of the NCCC as they relate to the social and environmental factors that influence the risk of type 2 diabetes and argue that the prevention and control of type 2 diabetes in the U.S. must begin with concrete population-level interventions to address social and environmental determinants of health. Frontiers Media S.A. 2023-06-15 /pmc/articles/PMC10310945/ /pubmed/37396183 http://dx.doi.org/10.3389/fendo.2023.1185719 Text en Copyright © 2023 Herman and Schillinger https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Herman, William H.
Schillinger, Dean
Rethinking diabetes in the United States
title Rethinking diabetes in the United States
title_full Rethinking diabetes in the United States
title_fullStr Rethinking diabetes in the United States
title_full_unstemmed Rethinking diabetes in the United States
title_short Rethinking diabetes in the United States
title_sort rethinking diabetes in the united states
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310945/
https://www.ncbi.nlm.nih.gov/pubmed/37396183
http://dx.doi.org/10.3389/fendo.2023.1185719
work_keys_str_mv AT hermanwilliamh rethinkingdiabetesintheunitedstates
AT schillingerdean rethinkingdiabetesintheunitedstates